dapsone has been researched along with HIV Coinfection in 84 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report here an unusual case of relapse of toxoplasmic encephalitis in an HIV-infected patient, possibly due to a drug-to-drug interaction between dapsone and minocycline." | 7.75 | Drug-to-drug interaction between dapsone and minocycline: an unusual cause of relapse of toxoplasmic encephalitis in an HIV-infected patient. ( Bigé, N; Gallien, S; Gervais, A; Kitzis, MD; Leport, C; Longuet, P, 2009) |
| "To the best of our knowledge, acute generalised exanthematous pustulosis has not been reported as a reaction to dapsone in the setting of HIV." | 5.39 | Acute generalised exanthematous pustulosis induced by Pneumocystis jirovecii pneumonia prophylaxis with dapsone. ( Laws, P; Marsland, A; McQuillan, O; Vas, A, 2013) |
| "We report two cases of symptomatic hyperbilirubinemia attributed to atazanavir in conjunction with the Pneumocystis jirovecii pneumonia prophylaxis agent dapsone." | 5.38 | Symptomatic hyperbilirubinemia secondary to dapsone-induced hemolysis and atazanavir therapy. ( Blanton, LS; East, J, 2012) |
| "We assessed the incidence and determinants of bacteremia, pneumonia, and sinusitis/otitis in HIV-positive people receiving cotrimoxazole (CTX) or dapsone-pyrimethamine (DP) for primary prophylaxis of Pneumocystis carinii pneumonia (PCP) and toxoplasmic encephalitis (TE) within a randomized clinical trial." | 5.09 | Incidence and determinants of bacterial infections in HIV-positive patients receiving anti-Pneumocystis carinii/Toxoplasma gondii primary prophylaxis within a randomized clinical trial. ( Ammassari, A; Antinori, A; Cingolani, A; De Luca, A; Grillo, R; Murri, R; Pallavicini, F; Pezzotti, P, 2001) |
| "In a meta-analysis, we examined the efficacy of aerosolized pentamidine, trimethoprim-sulfamethoxazole, and dapsone or dapsone/pyrimethamine for the prevention of Pneumocystis carinii pneumonia and toxoplasma encephalitis in patients with HIV infection." | 4.79 | Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients. ( Bucher, HC; Griffith, L; Guyatt, GH; Opravil, M, 1997) |
| " Histological analysis of one of these nodules resulted in diagnosis of chronic erythema elevatum diutinum and treatment with dapsone was initiated." | 3.76 | [Erythema elevatum diutinum associated with pyoderma gangrenosum in an HIV-positive patient]. ( Andre, C; Bagot, M; Duriez, P; Lascaux-Cametz, AS; Maksimovic, L; Ortonne, N; Revuz, J, 2010) |
| " We report here an unusual case of relapse of toxoplasmic encephalitis in an HIV-infected patient, possibly due to a drug-to-drug interaction between dapsone and minocycline." | 3.75 | Drug-to-drug interaction between dapsone and minocycline: an unusual cause of relapse of toxoplasmic encephalitis in an HIV-infected patient. ( Bigé, N; Gallien, S; Gervais, A; Kitzis, MD; Leport, C; Longuet, P, 2009) |
| "Dapsone clearance was increased by rifabutin or rifabutin plus fluconazole (67% and 38%, respectively) (n = 12, P < ." | 2.71 | The effect of clarithromycin, fluconazole, and rifabutin on dapsone hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283). ( Greenspan, DL; Hooton, TM; Jacobson, M; Slattery, JT; Trapnell, CB; Unadkat, JD; Winter, HR, 2004) |
| " For the entire population, the median half-life was 22." | 2.69 | Pharmacokinetics of dapsone administered daily and weekly in human immunodeficiency virus-infected children. ( Bonagura, VR; Cooper, E; Cunningham, CK; Dankner, W; Frenkel, LM; Jacobus, D; Johnson, D; Lindsey, J; McIntosh, K; McNamara, J; Mirochnick, M; Mofenson, L; Nachman, S; Rathore, MH; Sullivan, JL; Wara, DW; Xu, J, 1999) |
| " However, the suggested dosage regimen is based upon clinical experience with children with leprosy and dermatitis herpetiformis rather than pharmacokinetic and pharmacodynamic data obtained from the target patient population." | 2.68 | Pharmacokinetics of dapsone in human immunodeficiency virus-infected children. ( Bassetti, D; Casazza, R; Cruciani, M; Gatti, G; Loy, A; Miletich, F, 1995) |
| "Dapsone was discontinued in nine (39%) patients because of adverse reactions." | 2.67 | Utility of dapsone for prophylaxis of Pneumocystis carinii pneumonia in trimethoprim-sulfamethoxazole-intolerant, HIV-infected individuals. ( Horowitz, HW; Jorde, UP; Wormser, GP, 1993) |
| "Cancer was found to be associated with 9." | 2.61 | Erythema elevatum diutinum: a case report and review of literature. ( Doktor, V; Goodheart, H; Hadi, A; Phelps, R, 2019) |
| "The diagnosis of Pneumocystis carinii pneumonia (PCP) rests on the isolation of this micro-organism in patients whose latest blood count, less than 2 months old, shows less than 250 CD4 lymphocytes per cubic mm and who present with signs of impaired lung function." | 2.38 | [Pneumocystis carinii pneumonia in HIV infection. Diagnosis, prognostic factors and curative treatment]. ( Girard, PM; Saimot, AG, 1991) |
| "Although Pneumocystis carinii pneumonia (PCP) can occur in any patient with severe impairment of immunity, there has been a sharp rise in incidence with the spread of human immunodeficiency virus through the USA and Western Europe, where nearly 80% of patients with HIV infection have at least one episode of PCP during their lifetime (Murray et al, 1984)." | 2.38 | Prophylaxis and treatment of Pneumocystis carinii pneumonia. ( Bateman, NT; O'Doherty, MJ, 1991) |
| "To the best of our knowledge, acute generalised exanthematous pustulosis has not been reported as a reaction to dapsone in the setting of HIV." | 1.39 | Acute generalised exanthematous pustulosis induced by Pneumocystis jirovecii pneumonia prophylaxis with dapsone. ( Laws, P; Marsland, A; McQuillan, O; Vas, A, 2013) |
| "We report two cases of symptomatic hyperbilirubinemia attributed to atazanavir in conjunction with the Pneumocystis jirovecii pneumonia prophylaxis agent dapsone." | 1.38 | Symptomatic hyperbilirubinemia secondary to dapsone-induced hemolysis and atazanavir therapy. ( Blanton, LS; East, J, 2012) |
| "Methemoglobinemia is a rare pathology that results from the oxidation of iron in the hemoglobin molecule." | 1.38 | Two cases of acquired methemoglobinemia. ( Bergmans, D; Hall, A; Schnabel, R; Stessel, B, 2012) |
| "Overall, 75 (6." | 1.36 | Prevalence of G6PD deficiency in a large cohort of HIV-infected patients. ( Giordano, TP; Serpa, JA; Villarreal-Williams, E, 2010) |
| "Dapsone was used in the treatment of this patient, and partial regression of the lesions was achieved within 15 days, even before anti-retroviral therapy was prescribed." | 1.33 | Erythema elevatum diutinum as a first clinical manifestation for diagnosing HIV infection: case history. ( Arruda, LH; Bittencourt, C; Cintra, ML; Discacciati, MP; Rover, PA; Zaniboni, MC, 2005) |
| "Relapsing polychondritis is a rare autoimmune disease characterized by inflammation and degeneration of cartilaginous tissue." | 1.32 | Relapsing polychondritis in HIV-infected patients: a report of two cases. ( Berger, T; Dolev, JC; Maurer, TA; Ramirez, LE; Reddy, SG, 2004) |
| " Dosing or frequency of TMP-SMX did not seem to influence risk of chemoprophylaxis failure." | 1.30 | Pneumocystis carinii pneumonia incidence and chemoprophylaxis failure in ambulatory HIV-infected patients. HIV Outpatient Study (HOPS) Investigators. ( Holmberg, SD; Moorman, AC; Palella, FJ; Von Bargen, JC, 1998) |
| "Occurrence or recurrence of PCP." | 1.29 | Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study. ( Hoover, DR; Kingsley, LA; Peng, Y; Phair, JP; Saah, AJ; Schrager, LK; Visscher, B, 1995) |
| "Eczematous photosensitivity disorders have been reported in patients infected with the human immunodeficiency virus." | 1.29 | Photodistributed hypertrophic lichen planus in association with acquired immunodeficiency syndrome: a distinct entity. ( Fitzgerald, E; Goldman, HM; Purcell, SM, 1995) |
| "Major aphthous ulcers are associated with a high degree of morbidity in patients infected with human immunodeficiency virus." | 1.29 | Major aphthous ulcers in patients with HIV disease. ( Glick, M; Muzyka, BC, 1994) |
| "The overall incidence of adverse events (AE) in our study cohort was 39%." | 1.29 | Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole. ( Beumont, MG; Graziani, A; MacGregor, RR; Ubel, PA, 1996) |
| "Drug therapies for patients with human immunodeficiency virus (HIV) infection are associated with adverse events that can potentially limit their effectiveness." | 1.29 | Adverse events from drug therapy for human immunodeficiency virus disease. ( Chaisson, RE; Fortgang, I; Keruly, J; Moore, RD, 1996) |
| "Bacteremia was caused by Staphylococcus aureus (23%), Pseudomonas aeruginosa (18%), Escherichia coli (16%), Streptococcus pneumoniae (14%) and others (31%)." | 1.29 | Community-acquired bacteremia in HIV-positive patients: protective benefit of co-trimoxazole. ( Edge, MD; Rimland, D, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 47 (55.95) | 18.2507 |
| 2000's | 19 (22.62) | 29.6817 |
| 2010's | 16 (19.05) | 24.3611 |
| 2020's | 2 (2.38) | 2.80 |
| Authors | Studies |
|---|---|
| Kaur, M | 1 |
| Sahoo, AK | 1 |
| Gupta, S | 1 |
| Díaz-Morales, P | 1 |
| Grau-Pérez, M | 1 |
| De-La-Rosa-Del-Rey, MP | 1 |
| Cárdenes-Santana, MÁ | 1 |
| Doktor, V | 1 |
| Hadi, A | 2 |
| Phelps, R | 1 |
| Goodheart, H | 1 |
| Cardis, MA | 1 |
| Sowash, MG | 1 |
| Mosojane, KI | 1 |
| Kovarik, C | 1 |
| Williams, V | 1 |
| Varshney, E | 1 |
| Tandon, M | 1 |
| Saha, N | 1 |
| Ali, S | 1 |
| Quinn, K | 1 |
| Lountzis, N | 1 |
| Purcell, SM | 2 |
| Kathi, PR | 1 |
| Tama, M | 1 |
| Ehrinpreis, M | 1 |
| Mutchnick, M | 1 |
| Westerhoff, M | 1 |
| Mowers, J | 1 |
| Fontana, RJ | 1 |
| Vas, A | 1 |
| Laws, P | 1 |
| Marsland, A | 1 |
| McQuillan, O | 1 |
| Chaudhry, AA | 1 |
| Ellis, RM | 1 |
| Hood, AF | 1 |
| Victoria-Martínez, AM | 1 |
| Cubells-Sánchez, L | 1 |
| Martínez-Leborans, L | 1 |
| Sánchez-Carazo, JL | 1 |
| Alegre de Miquel, V | 1 |
| Inamadar, AC | 1 |
| Anitha, B | 1 |
| Gallien, S | 1 |
| Bigé, N | 1 |
| Kitzis, MD | 1 |
| Longuet, P | 1 |
| Gervais, A | 1 |
| Leport, C | 1 |
| Maksimovic, L | 1 |
| Duriez, P | 1 |
| Lascaux-Cametz, AS | 1 |
| Andre, C | 1 |
| Bagot, M | 1 |
| Revuz, J | 1 |
| Ortonne, N | 2 |
| Rubenstein, E | 1 |
| Krulig, E | 1 |
| Cardenas, V | 1 |
| Kerdel, FA | 1 |
| Serpa, JA | 1 |
| Villarreal-Williams, E | 1 |
| Giordano, TP | 1 |
| Manga, NM | 1 |
| Poda, A | 1 |
| Bazolo, N | 1 |
| Sané, O | 1 |
| Batista, G | 1 |
| Guèye, NF | 1 |
| Sow, PS | 1 |
| Badiane, CI | 1 |
| East, J | 1 |
| Blanton, LS | 1 |
| Hall, A | 1 |
| Stessel, B | 1 |
| Bergmans, D | 1 |
| Schnabel, R | 1 |
| Roxby, A | 1 |
| Jain, R | 1 |
| James, CW | 1 |
| McNelis, KC | 1 |
| Szabo, S | 1 |
| Dolev, JC | 1 |
| Maurer, TA | 1 |
| Reddy, SG | 1 |
| Ramirez, LE | 1 |
| Berger, T | 1 |
| Winter, HR | 1 |
| Trapnell, CB | 1 |
| Slattery, JT | 1 |
| Jacobson, M | 1 |
| Greenspan, DL | 1 |
| Hooton, TM | 2 |
| Unadkat, JD | 1 |
| Bellamy, R | 3 |
| Visco-Comandini, U | 1 |
| Longo, B | 1 |
| Cuzzi, T | 1 |
| Paglia, MG | 1 |
| Antonucci, G | 1 |
| Biswas, SK | 1 |
| Kumarasamy, N | 1 |
| Vallabhaneni, S | 1 |
| Cecelia, AJ | 1 |
| Mayer, KH | 1 |
| Solomon, S | 1 |
| Carpenter, CC | 1 |
| Flanigan, TP | 1 |
| Rover, PA | 1 |
| Bittencourt, C | 1 |
| Discacciati, MP | 1 |
| Zaniboni, MC | 1 |
| Arruda, LH | 1 |
| Cintra, ML | 1 |
| Martiniuk, F | 1 |
| Rao, SD | 1 |
| Rea, TH | 1 |
| Glickman, MS | 1 |
| Giovinazzo, J | 1 |
| Rom, WN | 1 |
| Cabrera, A | 1 |
| Levis, WR | 1 |
| Gatti, G | 3 |
| Loy, A | 1 |
| Casazza, R | 1 |
| Miletich, F | 2 |
| Cruciani, M | 3 |
| Bassetti, D | 3 |
| Hoernle, EH | 1 |
| Reid, TE | 1 |
| Saah, AJ | 1 |
| Hoover, DR | 1 |
| Peng, Y | 1 |
| Phair, JP | 1 |
| Visscher, B | 1 |
| Kingsley, LA | 1 |
| Schrager, LK | 1 |
| Fitzgerald, E | 1 |
| Goldman, HM | 1 |
| Opravil, M | 3 |
| Pechère, M | 1 |
| Lazzarin, A | 1 |
| Heald, A | 1 |
| Rüttimann, S | 1 |
| Iten, A | 1 |
| Furrer, H | 1 |
| Oertle, D | 1 |
| Praz, G | 1 |
| Vuitton, DA | 1 |
| Nachman, SA | 1 |
| Mueller, BU | 1 |
| Mirochnick, M | 2 |
| Pizzo, PA | 1 |
| Joos, B | 1 |
| Lüthy, R | 1 |
| Huengsberg, M | 1 |
| Castelino, S | 1 |
| Sherrard, J | 1 |
| O'Farrell, N | 1 |
| Bingham, J | 1 |
| Muzyka, BC | 1 |
| Glick, M | 1 |
| Concia, E | 1 |
| Fioredda, F | 1 |
| Barnett, JM | 1 |
| Lang, W | 1 |
| Osmond, D | 1 |
| Page-Bodkin, K | 1 |
| Moss, A | 1 |
| Winkelstein, W | 1 |
| Mallolas, J | 1 |
| Zamora, L | 1 |
| Gatell, JM | 1 |
| Miró, JM | 1 |
| Vernet, E | 1 |
| Valls, ME | 1 |
| Soriano, E | 1 |
| SanMiguel, JG | 1 |
| Jorde, UP | 2 |
| Horowitz, HW | 3 |
| Wormser, GP | 3 |
| Girard, PM | 2 |
| Landman, R | 1 |
| Gaudebout, C | 2 |
| Olivares, R | 1 |
| Saimot, AG | 2 |
| Jelazko, P | 1 |
| Certain, A | 1 |
| Boué, F | 1 |
| Bouvet, E | 1 |
| Podzamczer, D | 1 |
| Santín, M | 1 |
| Jimenez, J | 1 |
| Casanova, A | 1 |
| Bolao, F | 1 |
| Gudiol, GR | 1 |
| Jacobus, DP | 1 |
| Beumont, MG | 1 |
| Graziani, A | 1 |
| Ubel, PA | 1 |
| MacGregor, RR | 1 |
| Moore, RD | 1 |
| Fortgang, I | 1 |
| Keruly, J | 1 |
| Chaisson, RE | 1 |
| Pirmohamed, M | 1 |
| Williams, D | 1 |
| Tingle, MD | 1 |
| Barry, M | 1 |
| Khoo, SH | 1 |
| O'Mahony, C | 1 |
| Wilkins, EG | 1 |
| Breckenridge, AM | 1 |
| Park, BK | 1 |
| Durand, JM | 2 |
| Lefevre, P | 2 |
| Cretel, E | 1 |
| Kaplanski, G | 1 |
| Soubeyrand, J | 1 |
| Bourdillon, F | 1 |
| André, E | 1 |
| Nadal, JM | 1 |
| Delfraissy, JF | 1 |
| Bez, G | 1 |
| Barber, BA | 1 |
| Pegram, PS | 1 |
| High, KP | 1 |
| Edge, MD | 1 |
| Rimland, D | 1 |
| Mengoli, C | 1 |
| Cazzadori, A | 1 |
| Lazzarini, L | 1 |
| Graziani, MS | 1 |
| Malena, M | 1 |
| Bucher, HC | 1 |
| Griffith, L | 1 |
| Guyatt, GH | 1 |
| Suárez, J | 1 |
| Miguélez, M | 1 |
| Villalba, R | 1 |
| Moorman, AC | 1 |
| Von Bargen, JC | 1 |
| Palella, FJ | 1 |
| Holmberg, SD | 1 |
| Sackoff, J | 1 |
| McFarland, J | 1 |
| Su, S | 1 |
| Bryan, E | 1 |
| El-Sadr, WM | 1 |
| Murphy, RL | 1 |
| Yurik, TM | 1 |
| Luskin-Hawk, R | 1 |
| Cheung, TW | 1 |
| Balfour, HH | 1 |
| Eng, R | 1 |
| Kerkering, TM | 1 |
| Schutz, M | 1 |
| van der Horst, C | 1 |
| Hafner, R | 2 |
| Cooper, E | 1 |
| McIntosh, K | 1 |
| Xu, J | 1 |
| Lindsey, J | 1 |
| Jacobus, D | 1 |
| Mofenson, L | 1 |
| Sullivan, JL | 1 |
| Dankner, W | 1 |
| Frenkel, LM | 1 |
| Nachman, S | 1 |
| Wara, DW | 1 |
| Johnson, D | 1 |
| Bonagura, VR | 1 |
| Rathore, MH | 1 |
| Cunningham, CK | 1 |
| McNamara, J | 1 |
| Reilly, TP | 1 |
| MacArthur, RD | 2 |
| Farrough, MJ | 2 |
| Crane, LR | 2 |
| Woster, PM | 1 |
| Svensson, CK | 2 |
| Saillourglénisson, F | 1 |
| Chêne, G | 1 |
| Salmi, LR | 1 |
| Salamon, R | 1 |
| O'Neil, WM | 1 |
| Drobitch, RK | 1 |
| Doll, MA | 1 |
| Fretland, AJ | 1 |
| Hein, DW | 1 |
| Sundar, K | 1 |
| Rosado-Santos, H | 1 |
| Reimer, L | 1 |
| Murray, K | 1 |
| Michael, J | 1 |
| Chaloner, K | 1 |
| Rhame, FS | 1 |
| Murri, R | 2 |
| Ammassari, A | 1 |
| Pezzotti, P | 1 |
| Cingolani, A | 1 |
| De Luca, A | 2 |
| Pallavicini, F | 1 |
| Grillo, R | 1 |
| Antinori, A | 2 |
| Fakheri, A | 1 |
| Gupta, SM | 1 |
| White, SM | 1 |
| Don, PC | 1 |
| Weinberg, JM | 1 |
| Tamburrini, E | 1 |
| Ortona, L | 1 |
| Blum, RN | 1 |
| Miller, LA | 1 |
| Gaggini, LC | 1 |
| Cohn, DL | 1 |
| O'Doherty, MJ | 1 |
| Bateman, NT | 1 |
| Gallant, JE | 1 |
| Hoehn-Saric, E | 1 |
| Smith, MD | 1 |
| Costantino, M | 1 |
| Clotet, B | 1 |
| Sirera, G | 1 |
| Romeu, J | 1 |
| Gimeno, JM | 1 |
| Jou, A | 1 |
| Condom, MJ | 1 |
| Tor, J | 1 |
| Foz, M | 1 |
| Hovette, P | 1 |
| Issifi, S | 1 |
| Mongin, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides[NCT00000802] | Phase 3 | 700 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 reviews available for dapsone and HIV Coinfection
| Article | Year |
|---|---|
Erythema elevatum diutinum: a case report and review of literature.
Topics: Arthritis, Rheumatoid; Comorbidity; Dapsone; Folic Acid Antagonists; HIV Infections; Humans; Male; M | 2019 |
HIV-associated erythema elevatum diutinum: a case report and review of a clinically distinct variant.
Topics: Anti-Infective Agents; Anti-Retroviral Agents; Dapsone; HIV Infections; Humans; Male; Vasculitis, Le | 2018 |
Pneumocystis carinii pneumonia treatment in people infected with HIV.
Topics: Antifungal Agents; Atovaquone; Clindamycin; Dapsone; Drug Therapy, Combination; HIV Infections; Huma | 2004 |
Pneumocystis pneumonia in people with HIV.
Topics: Atovaquone; Clindamycin; Corticosterone; Dapsone; Drug Therapy, Combination; HIV Infections; Humans; | 2005 |
Pneumocystis pneumonia in people with HIV.
Topics: Anti-Infective Agents; Antiprotozoal Agents; Atovaquone; Clindamycin; Dapsone; Drug Therapy, Combina | 2006 |
Human immunodeficiency virus infection in children.
Topics: Adolescent; AIDS-Related Opportunistic Infections; Child; Child, Preschool; Dapsone; Didanosine; Dru | 1995 |
Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
Topics: Administration, Inhalation; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal | 1997 |
[Effect of dapsone on survival in HIV infected patients: a meta- analysis of finished trials].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Anti-Inflammatory Agents, Non-S | 2000 |
[Pneumocystis carinii pneumonia in HIV infection. Diagnosis, prognostic factors and curative treatment].
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; CD4-Positive T-Lymphocytes; Dapsone; Eflornithine; F | 1991 |
Prophylaxis and treatment of Pneumocystis carinii pneumonia.
Topics: Antimalarials; CD4-Positive T-Lymphocytes; Clinical Protocols; Dapsone; Drug Combinations; HIV Infec | 1991 |
[Pneumocystis carinii pneumonia in HIV infections. Committee of the 1st Consensus Conference of anti-infectious therapy organized in May 1990 in Paris by the Société de Pathologie Infectieuse de Langue Française].
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Clinical Protocols; Dapsone; France; HIV Infections; H | 1990 |
[Consensus conference: pneumocystosis in HIV infections. 1st consensus conference in anti-infection therapeutics organized by "la Société de Pathologie Infectieuse de langue française", May 11, 1990].
Topics: Adrenal Cortex Hormones; Dapsone; France; HIV Infections; Humans; Opportunistic Infections; Pentamid | 1990 |
16 trials available for dapsone and HIV Coinfection
| Article | Year |
|---|---|
The effect of clarithromycin, fluconazole, and rifabutin on dapsone hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283).
Topics: Adult; Algorithms; Anti-Bacterial Agents; Antifungal Agents; Area Under Curve; CD4 Lymphocyte Count; | 2004 |
Pharmacokinetics of dapsone in human immunodeficiency virus-infected children.
Topics: Aging; Anti-Infective Agents; Child; Child, Preschool; Dapsone; Female; Half-Life; HIV Infections; H | 1995 |
Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressed patients infected with the human immunodeficiency virus.
Topics: Adult; CD4 Lymphocyte Count; Dapsone; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Huma | 1995 |
Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.
Topics: Adult; Aerosols; AIDS-Related Opportunistic Infections; Antifungal Agents; Dapsone; Drug Therapy, Co | 1993 |
Utility of dapsone for prophylaxis of Pneumocystis carinii pneumonia in trimethoprim-sulfamethoxazole-intolerant, HIV-infected individuals.
Topics: Adult; AIDS-Related Opportunistic Infections; Contraindications; Dapsone; Drug Eruptions; Female; Fe | 1993 |
Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
Topics: Adult; AIDS-Related Complex; AIDS-Related Opportunistic Infections; Dapsone; Drug Combinations; Ence | 1993 |
Thrice-weekly cotrimoxazole is better than weekly dapsone-pyrimethamine for the primary prevention of Pneumocystis carinii pneumonia in HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Dapsone; Drug Administration Schedule; Drug Therapy, C | 1993 |
Randomization to iron supplementation of patients with advanced human immunodeficiency virus disease--an inadvertent but controlled study with results important for patient care.
Topics: Dapsone; HIV Infections; Humans; Iron | 1996 |
Penetration of dapsone into pulmonary lining fluid of human immunodeficiency virus type 1-infected patients.
Topics: Adult; Bronchoalveolar Lavage Fluid; Bronchoscopy; Chromatography, High Pressure Liquid; Dapsone; Fe | 1997 |
Prophylaxis for opportunistic infections among HIV-infected patients receiving medical care.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Analysis of Variance; Anti-Infective Agent | 1998 |
Atovaquone compared with dapsone for the prevention of Pneumocystis carinii pneumonia in patients with HIV infection who cannot tolerate trimethoprim, sulfonamides, or both. Community Program for Clinical Research on AIDS and the AIDS Clinical Trials Grou
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Atovaquone; Dapsone; Female; Fo | 1998 |
Pharmacokinetics of dapsone administered daily and weekly in human immunodeficiency virus-infected children.
Topics: Adolescent; Anti-Infective Agents; Child; Child, Preschool; Chromatography, High Pressure Liquid; Da | 1999 |
Is hydroxylamine-induced cytotoxicity a valid marker for hypersensitivity reactions to sulfamethoxazole in human immunodeficiency virus-infected individuals?
Topics: Adult; Anti-Infective Agents; Benzoxazoles; Biomarkers; Cell Separation; Cell Survival; Dapsone; Dru | 1999 |
Incidence and determinants of bacterial infections in HIV-positive patients receiving anti-Pneumocystis carinii/Toxoplasma gondii primary prophylaxis within a randomized clinical trial.
Topics: Adult; Animals; Anti-Infective Agents; Bacterial Infections; Dapsone; Encephalitis; Female; HIV Infe | 2001 |
Failure of low-dose dapsone-pyrimethamine in primary prophylaxis of Pneumocystis carinii pneumonia.
Topics: Dapsone; Drug Therapy, Combination; HIV Infections; Humans; Pneumonia, Pneumocystis; Pyrimethamine; | 1992 |
Comparative trial of dapsone versus trimethoprim/sulfamethoxazole for primary prophylaxis of Pneumocystis carinii pneumonia.
Topics: Adult; Dapsone; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infec | 1992 |
56 other studies available for dapsone and HIV Coinfection
| Article | Year |
|---|---|
Unusual presentation of erythema elevatum diutinum in an HIV-positive man with dramatic response to dapsone.
Topics: Adult; Anti-Infective Agents; Antiretroviral Therapy, Highly Active; Dapsone; HIV Infections; Humans | 2019 |
'String of Pearls' Sign Revealing Linear IgA Bullous Disease.
Topics: Anti-Infective Agents; Dapsone; HIV Infections; Humans; Linear IgA Bullous Dermatosis; Male; Young A | 2021 |
In vivo phenotyping of cytochrome 450 isoforms involved in the metabolism of anti-HIV and anti-tubercular drugs in human using cocktail approach: An LC-MS/MS analysis.
Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Arylamine N-Acetyltransferase; Bupropion; Coinfection | 2019 |
Relapsing polychondritis in human immunodeficiency virus.
Topics: Adult; Dapsone; Diagnosis, Differential; Ear, External; HIV Infections; Humans; Male; Polychondritis | 2019 |
Vanishing bile duct syndrome arising in a patient with HIV infection sequentially treated with trimethoprim/sulfamethoxazole and dapsone.
Topics: Anti-Infective Agents; Cholestasis, Intrahepatic; Dapsone; Drug Interactions; Drug Therapy, Combinat | 2020 |
Acute generalised exanthematous pustulosis induced by Pneumocystis jirovecii pneumonia prophylaxis with dapsone.
Topics: Acute Generalized Exanthematous Pustulosis; Adult; AIDS-Related Opportunistic Infections; Anti-Infec | 2013 |
Tense bullae with widespread erosions.
Topics: CD4 Lymphocyte Count; Dapsone; Fluorescent Antibody Technique, Direct; Folic Acid Antagonists; HIV I | 2015 |
A man with HIV and papules and nodules on the knees.
Topics: Administration, Topical; Adult; Anti-Infective Agents; Anti-Retroviral Agents; Biopsy; Dapsone; Diag | 2016 |
HIV-seropositive patient with Sweet's syndrome and nodular scleritis, showing dramatic response after adding dapsone to systemic corticosteroid therapy.
Topics: Administration, Oral; Adult; Dapsone; Dose-Response Relationship, Drug; Drug Administration Schedule | 2008 |
Drug-to-drug interaction between dapsone and minocycline: an unusual cause of relapse of toxoplasmic encephalitis in an HIV-infected patient.
Topics: Adult; Dapsone; Drug Interactions; Encephalitis; HIV Infections; HIV-1; Humans; Male; Minocycline; R | 2009 |
[Erythema elevatum diutinum associated with pyoderma gangrenosum in an HIV-positive patient].
Topics: Dapsone; Dermis; Erythema; Foot Diseases; HIV Infections; Humans; Male; Middle Aged; Neutrophils; Py | 2010 |
Botryomycosis-like pyoderma in the genital region of a human immunodeficiency virus (HIV)-positive man successfully treated with dapsone.
Topics: Anti-Infective Agents; Dapsone; HIV Infections; Humans; Male; Middle Aged; Penis; Pseudomonas Infect | 2010 |
Prevalence of G6PD deficiency in a large cohort of HIV-infected patients.
Topics: Adult; Aged; Anemia, Hemolytic; Anti-Infective Agents; Black or African American; Cohort Studies; Da | 2010 |
[Immune reconstitution inflammatory syndrome and HIV leprosy co-infection].
Topics: Adrenal Cortex Hormones; Adult; Anti-HIV Agents; Dapsone; Diagnostic Errors; Female; HIV Infections; | 2011 |
[Cutaneous neutrophils infiltrates. Case 2. Erythema elevatum diutinum, late stage].
Topics: Dapsone; Diagnosis, Differential; Fibrosis; Foot Dermatoses; Foot Ulcer; Granuloma; HIV Infections; | 2011 |
Symptomatic hyperbilirubinemia secondary to dapsone-induced hemolysis and atazanavir therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Anemia, Hemolytic; Anti-HIV Agents; Anti-Infective Age | 2012 |
Two cases of acquired methemoglobinemia.
Topics: Anti-Infective Agents; Antidotes; Dapsone; Female; HIV Infections; HIV-1; Humans; Male; Methemoglobi | 2012 |
Dapsone interferes with hemoglobin A1c monitoring of diabetes in an HIV-infected patient.
Topics: Blood Glucose; Burkitt Lymphoma; CD4 Lymphocyte Count; Chromatography, High Pressure Liquid; Dapsone | 2013 |
Reinstituting trimethoprim--sulfamethoxazole in patients receiving atovaquone for Pneumocystis carinii pneumonia prophylaxis.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Atovaquone; Clinical Protocols; Dapson | 2003 |
Relapsing polychondritis in HIV-infected patients: a report of two cases.
Topics: Adult; Anti-Inflammatory Agents; Dapsone; HIV Infections; Humans; Male; Polychondritis, Relapsing; P | 2004 |
Tuberculoid leprosy in a patient with AIDS: a manifestation of immune restoration syndrome.
Topics: Adult; Antiretroviral Therapy, Highly Active; Dapsone; HIV Infections; HIV-1; Humans; Leprostatic Ag | 2004 |
Chemotherapy of leprosy.
Topics: Anti-Bacterial Agents; Clofazimine; Dapsone; Dose-Response Relationship, Drug; Drug Combinations; Dr | 2004 |
Safe discontinuation of primary pneumocystis prophylaxis in Southern Indian HIV-infected patients on highly active antiretroviral therapy.
Topics: Anti-Infective Agents; Anti-Retroviral Agents; Antiprotozoal Agents; Antiretroviral Therapy, Highly | 2005 |
Erythema elevatum diutinum as a first clinical manifestation for diagnosing HIV infection: case history.
Topics: Anti-Infective Agents; Dapsone; Erythema; HIV Infections; Humans; Male; Middle Aged; Vasculitis, Leu | 2005 |
Leprosy as immune reconstitution inflammatory syndrome in HIV-positive persons.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dapsone; HIV Infections; Humans; Immu | 2007 |
Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
Topics: Adult; AIDS-Related Opportunistic Infections; CD4 Lymphocyte Count; Dapsone; HIV Infections; HIV-1; | 1995 |
Photodistributed hypertrophic lichen planus in association with acquired immunodeficiency syndrome: a distinct entity.
Topics: Adrenal Cortex Hormones; Adult; Biopsy; Dapsone; HIV Infections; Humans; Lichen Planus; Male; Photos | 1995 |
High failure rate of dapsone and pentamidine as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected children.
Topics: Child, Preschool; Dapsone; HIV Infections; Humans; Infant; Male; Pneumonia, Pneumocystis; Trimethopr | 1994 |
Levels of dapsone and pyrimethamine in serum during once-weekly dosing for prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
Topics: Adult; Aged; Dapsone; Drug Interactions; Female; HIV Infections; Humans; Male; Middle Aged; Phenotyp | 1994 |
Does drug interaction cause failure of PCP prophylaxis with dapsone?
Topics: Dapsone; Didanosine; Drug Interactions; HIV Infections; Humans; Pneumonia, Pneumocystis; Retrospecti | 1993 |
Major aphthous ulcers in patients with HIV disease.
Topics: Adult; Biomarkers; CD4-CD8 Ratio; Dapsone; Ethnicity; Female; HIV Infections; Humans; Immune Toleran | 1994 |
Dapsone prophylaxis against Pneumocystis carinii pneumonia in human immunodeficiency virus-infected children.
Topics: Child; Child, Preschool; Dapsone; HIV Infections; Humans; Infant; Pneumonia, Pneumocystis | 1994 |
Clinical pharmacology.
Topics: Dapsone; HIV Infections; Humans; Pharmacology, Clinical | 1993 |
Population-based estimates of antiretroviral therapy and anti-Pneumocystis prophylaxis in San Francisco: 1991.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antiviral Agents; Cohort Studies; Daps | 1993 |
Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole.
Topics: Adult; Anti-Infective Agents; Anti-Infective Agents, Urinary; Dapsone; Dose-Response Relationship, D | 1996 |
Adverse events from drug therapy for human immunodeficiency virus disease.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Dapsone; Didanosine; Female; HIV Infections; Humans; | 1996 |
Intracellular glutathione in the peripheral blood cells of HIV-infected patients: failure to show a deficiency.
Topics: Adult; Aged; CD4 Lymphocyte Count; Dapsone; Drug Hypersensitivity; Erythrocytes; Glutathione; HIV In | 1996 |
Dapsone therapy for thrombocytopenia in patients infected with human immunodeficiency virus.
Topics: Dapsone; HIV Infections; Humans; Thrombocytopenia | 1996 |
[Prescription of antiretroviral and prophylactic drugs in HIV diseases: reality of medical practices].
Topics: Anti-Infective Agents; Antiviral Agents; CD4 Lymphocyte Count; Dapsone; Didanosine; Drug Utilization | 1995 |
Clindamycin/primaquine as prophylaxis for Pneumocystis carinii pneumonia.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antimalarials; CD4 Lymphocyte Count; Clindamyci | 1996 |
Community-acquired bacteremia in HIV-positive patients: protective benefit of co-trimoxazole.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Bacteremia; Community-Acquired | 1996 |
Nodular erythema elevatum diutinum in an HIV-1 infected woman: response to dapsone and antiretroviral therapy.
Topics: Adult; Antiviral Agents; Dapsone; Erythema; Female; HIV Infections; HIV-1; Humans; Vasculitis, Leuko | 1998 |
Pneumocystis carinii pneumonia incidence and chemoprophylaxis failure in ambulatory HIV-infected patients. HIV Outpatient Study (HOPS) Investigators.
Topics: Adult; AIDS-Related Opportunistic Infections; Ambulatory Care; Anti-Infective Agents; Antifungal Age | 1998 |
Atovaquone compared with dapsone to prevent Pneumocystis carinii pneumonia.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Atovaquone; Dapsone; Drug Costs; HIV I | 1999 |
Acetylator phenotype and genotype in patients infected with HIV: discordance between methods for phenotype determination and genotype.
Topics: Acetylation; Adult; Antigens, CD; Arylamine N-Acetyltransferase; Base Sequence; Caffeine; Dapsone; D | 2000 |
Unusual presentation of thoracic Pneumocystis carinii infection in a patient with acquired immunodeficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Biopsy; Dapsone; Diagnosis, Dif | 2001 |
Quantifying and documenting prior beliefs in clinical trials.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Atovaquone; Attitud | 2001 |
PCP prevention for children.
Topics: Antifungal Agents; Atovaquone; Clinical Trials as Topic; Dapsone; HIV Infections; Infant; Infant, Ne | 1995 |
Erythema elevatum diutinum in a patient with human immunodeficiency virus.
Topics: Anti-Infective Agents; Dapsone; Erythema; HIV Infections; Humans; Leg Dermatoses; Male; Middle Aged | 2001 |
Drug interactions in use of dapsone for Pneumocystis carinii prophylaxis.
Topics: Dapsone; Drug Interactions; HIV Infections; Humans; Pneumonia, Pneumocystis; Rifampin | 1992 |
Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus.
Topics: Aerosols; CD4-Positive T-Lymphocytes; Child; Child, Preschool; Clinical Protocols; Dapsone; Drug Adm | 1991 |
From the Centers for Disease Control. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus.
Topics: Aerosols; CD4-Positive T-Lymphocytes; Child; Child, Preschool; Clinical Protocols; Dapsone; Drug Adm | 1991 |
Respiratory insufficiency from dapsone-induced methemoglobinemia.
Topics: Adult; Dapsone; HIV Infections; Humans; Male; Methemoglobinemia; Opportunistic Infections; Pneumonia | 1991 |
[Some aspects of the treatment of HIV infection].
Topics: Acquired Immunodeficiency Syndrome; Clindamycin; Dapsone; HIV Infections; Humans; Primaquine; Trimet | 1991 |
Twice-weekly dapsone-pyrimethamine for preventing PCP and cerebral toxoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Brain Diseases; Dapsone; Drug Administration Schedule; Drug Ther | 1991 |
Dapsone for thrombocytopenic purpura related to human immunodeficiency virus infection.
Topics: Adult; Autoimmune Diseases; Dapsone; Female; HIV Infections; Humans; Leukocyte Count; Male; Middle A | 1991 |